Opens in a new tab
Monday, 16 November 2026
EVIDENCE. INTERPRETED.
Health Tidings

Generics

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Generics

59 stories · every one Fact-Checked
Dr. Reddy’s twice-yearly injectable generic lenacapavir for HIV preventionGenericsDr. Reddy’s Wins FDA Approval for Generic Lenacapavir Across LMICsDr. Reddy’s Laboratories has secured tentative FDA approval for its generic twice-yearly injectable lenacapavir for HIV prevention.3 Nov 2026 · 4 min read
Fact-Checked
Minimalist illustration of a once-weekly estradiol and levonorgestrel hormone therapy patch for menopause treatment.GenericsZydus Gains FDA Approval for Weekly Menopause Hormone TherapyThe FDA has approved Zydus Pharmaceuticals’ first generic version of Climara Pro, a once-weekly estradiol and levonorgestrel patch for treating moderate-to-severe menopausal vasomotor symptoms and preventing postmenopausal osteoporosis…21 Oct 2026 · 4 min read
Fact-Checked
Alcon Brytly apraclonidine 0.125% eye drops approved by the FDA for temporary relief of eye redness caused by minor irritation.GenericsFDA Approves Alcon’s Brytly Eye Drops for Redness ReliefThe FDA has approved Alcon’s Brytly (apraclonidine ophthalmic solution 0.125%) for temporary relief of eye redness caused by minor irritations.16 Oct 2026 · 3 min read
Fact-Checked
Lupin Formoflo-G MDI triple-combination inhaler for moderate to severe COPDGenericsLupin Launches Formoflo-G MDI in India for COPD Triple TherapyLupin has launched Formoflo-G MDI in India, a fixed-dose triple-combination inhaler containing glycopyrronium bromide, formoterol fumarate and fluticasone propionate for the long-term management of moderate to severe COPD.6 Oct 2026 · 3 min read
Fact-Checked
Teva DEGEVMA denosumab biosimilar receives FDA approval as Xgeva biosimilarGenericsTeva’s DEGEVMA Receives U.S. FDA Approval as Biosimilar to XgevaTeva’s DEGEVMA (denosumab-adet) has received FDA approval as a biosimilar to Xgeva, covering its approved indications and becoming Teva’s second FDA-approved biosimilar of 2026.29 Sep 2026 · 4 min read
Fact-Checked
Lupin apixaban oral suspension 1.25 mg/mL receives tentative FDA approval under 505(b)(2) pathwayGenericsLupin Secures U.S. FDA Tentative Approval for Apixaban Oral SuspensionLupin has received tentative U.S. FDA approval for apixaban oral suspension 1.25 mg/mL under the 505(b)(2) pathway, providing a potential liquid administration option for adults requiring anticoagulation who…28 Sep 2026 · 3 min read
Fact-Checked
Lupin Modafinil Tablets USP 100 mg and 200 mg receive U.S. FDA approvalGenericsLupin Secures U.S. FDA Approval for Generic Modafinil Tablets (100 mg and 200 mg)Lupin has received U.S. FDA approval for Modafinil Tablets USP 100 mg and 200 mg, bioequivalent to Provigil, for improving wakefulness in adults with excessive sleepiness associated with…5 Sep 2026 · 2 min read
Fact-Checked
Zydus Ascorbic Acid Injection USP approved by FDA for short-term treatment of scurvyGenericsZydus Secures USFDA Approval for Ascorbic Acid Injection for ScurvyZydus Lifesciences has received USFDA approval for Ascorbic Acid Injection USP, a generic intravenous vitamin C treatment for scurvy in adults and pediatric patients aged 5 months and…24 Aug 2026 · 3 min read
Fact-Checked
Glenmark Fluticasone Propionate Nasal Spray receives U.S. FDA approvalGenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal SprayGlenmark Pharmaceuticals has received U.S. FDA approval for Fluticasone Propionate Nasal Spray USP 0.05 mg/spray, a product bioequivalent and therapeutically equivalent to Flonase Nasal Spray.20 Aug 2026 · 3 min read
Fact-Checked
YESINTEK ustekinumab-kfce autoinjector pen presentation for subcutaneous injectionGenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled AutoinjectorBiocon Limited has secured supplemental US FDA approval for single-dose prefilled autoinjector options of YESINTEK® (ustekinumab-kfce).18 Aug 2026 · 2 min read
Fact-Checked
Zydus Lifesciences receives USFDA approval for generic Indocyanine Green for Injection with 180-day Competitive Generic Therapy exclusivityGenericsZydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-day CGT exclusivityZydus Lifesciences has received USFDA approval for its generic Indocyanine Green for Injection, USP, 25 mg/vial.5 Aug 2026 · 3 min read
Fact-Checked
FDA approves Garzulys (insulin aspart-fsan), a biosimilar to NovoLog, for improving glycemic control in adults and children with diabetes mellitus.GenericsFDA Approves Garzulys Biosimilar to NovoLog for Adults and Children with DiabetesThe U.S. FDA has approved Garzulys (insulin aspart-fsan), a rapid-acting biosimilar to NovoLog, for improving glycemic control in adults and pediatric patients with diabetes mellitus.4 Aug 2026 · 3 min read
Fact-Checked
Page 1 of 5